ERBB2 and ovarian carcinoma: While studies of snaR-A ncRNA are currently limited, SNAR-A has been shown to be upregulated in hepatocellular and ovarian carcinoma and HER2-positive breast cancer cells and, like POLR3G, immortalized cell lines25–27.